VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 151 filers reported holding VERACYTE INC in Q1 2019. The put-call ratio across all filers is 2.87 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,091,000 | -41.0% | 65,735 | -29.3% | 1.38% | -20.4% |
| Q2 2022 | $1,850,000 | +772.6% | 92,971 | +2050.6% | 1.73% | +1070.3% |
| Q4 2020 | $212,000 | -41.6% | 4,323 | -61.3% | 0.15% | -49.5% |
| Q3 2020 | $363,000 | -47.8% | 11,171 | -58.4% | 0.29% | -58.8% |
| Q2 2020 | $696,000 | -40.4% | 26,855 | -44.1% | 0.71% | -59.6% |
| Q1 2020 | $1,167,000 | -21.9% | 48,024 | -10.3% | 1.76% | +8.4% |
| Q4 2019 | $1,495,000 | -26.7% | 53,540 | -37.0% | 1.63% | -32.0% |
| Q3 2019 | $2,040,000 | -2.0% | 85,000 | +16.4% | 2.39% | +11.2% |
| Q2 2019 | $2,081,000 | -37.5% | 73,000 | -45.1% | 2.15% | -23.3% |
| Q1 2019 | $3,327,000 | +26.0% | 133,000 | -36.7% | 2.81% | +16.0% |
| Q4 2018 | $2,641,000 | -1.2% | 210,000 | -25.0% | 2.42% | +16.1% |
| Q3 2018 | $2,674,000 | +24.5% | 280,000 | +21.7% | 2.08% | +27.2% |
| Q2 2018 | $2,148,000 | – | 230,000 | – | 1.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |